• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮-间充质转化标志物在 HCV 相关肝细胞癌中的作用:一项多变量随访研究。

Epithelial-Mesenchymal Transition Markers in HCVAssociated Hepatocellular Carcinoma: A Multivariate Follow Up Study.

机构信息

Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo Egypt.

October University for Modern Science and Arts, Giza, Egypt.

出版信息

Asian Pac J Cancer Prev. 2022 Mar 1;23(3):839-849. doi: 10.31557/APJCP.2022.23.3.839.

DOI:10.31557/APJCP.2022.23.3.839
PMID:35345355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9360938/
Abstract

OBJECTIVE

Validated markers to predict recurrence after surgical resection of hepatocellular carcinoma (HCC) are needed. Little data is available regarding epithelial-mesenchymal transition (EMT) markers in HCC. The objective of this study was to investigate the expression of EMT markers and their correlation with clinicopathological variables and survival in hepatitis C virus (HCV)-associated HCC.

METHODS

This longitudinal study included 109 cases of HCV-associated HCC treated with surgical resection. Nine different EMT markers (vimentin, E-cadherin, N-cadherin, Stat3, Snail1, Slug, Twist1, Zeb1 and integrin α5) were evaluated on liver tissue from HCC cases. Twenty fresh HCC samples from the studied cases were used for gene expression of EMT markers by quantitative real time polymerase chain reaction (PCR).

RESULTS

EMT markers expression was 71%, 25%, 26%, 27%, 9%, 4%, 72%, 47%, 87% for vimentin, E-cadherin, N-cadherin, Stat3 snail1, slug, twist1, Zeb1 and integrin α5 respectively.  EMT mRNA in HCC tissues correlated with protein expression by 50-70%.  Vimentin was independent predictor of large tumor size (P=0.001), high risk of recurrence (HRR) (P=0.006) and shorter disease free survival (P=0.03) in multivariate analysis.  Reduced E-cadherin was a predictor of HRR (P=0.002).

CONCLUSION

Vimentin and E-cadherin were the most powerful prognostic EMT markers in HCV-associated HCC in prediction of recurrence.

摘要

目的

需要有效的标志物来预测肝细胞癌 (HCC) 手术后的复发。关于 HCC 中的上皮-间充质转化 (EMT) 标志物,数据很少。本研究的目的是探讨 EMT 标志物的表达及其与丙型肝炎病毒 (HCV) 相关 HCC 的临床病理变量和生存的相关性。

方法

本纵向研究纳入了 109 例接受手术切除治疗的 HCV 相关 HCC 病例。评估了 HCC 病例肝组织中的 9 种不同的 EMT 标志物(波形蛋白、E-钙黏蛋白、N-钙黏蛋白、Stat3、Snail1、Slug、Twist1、Zeb1 和整合素α5)。对来自研究病例的 20 个新鲜 HCC 样本进行 EMT 标志物的基因表达定量实时聚合酶链反应 (PCR)。

结果

EMT 标志物的表达分别为 71%、25%、26%、27%、9%、4%、72%、47%、87%,对应的标志物为波形蛋白、E-钙黏蛋白、N-钙黏蛋白、Stat3、Snail1、Slug、Twist1、Zeb1 和整合素α5。HCC 组织中的 EMT mRNA 与蛋白表达相关 50-70%。在多变量分析中,波形蛋白是大肿瘤大小 (P=0.001)、高复发风险 (HRR) (P=0.006) 和无病生存时间较短 (P=0.03) 的独立预测因子。E-钙黏蛋白减少是 HRR 的预测因子 (P=0.002)。

结论

在预测复发方面,波形蛋白和 E-钙黏蛋白是 HCV 相关 HCC 中最强大的 EMT 预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/e17577798870/APJCP-23-839-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/b1ab117c3aad/APJCP-23-839-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/bdb95aef27fd/APJCP-23-839-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/7bfa244062dd/APJCP-23-839-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/e17577798870/APJCP-23-839-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/b1ab117c3aad/APJCP-23-839-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/bdb95aef27fd/APJCP-23-839-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/7bfa244062dd/APJCP-23-839-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f5/9360938/e17577798870/APJCP-23-839-g004.jpg

相似文献

1
Epithelial-Mesenchymal Transition Markers in HCVAssociated Hepatocellular Carcinoma: A Multivariate Follow Up Study.上皮-间充质转化标志物在 HCV 相关肝细胞癌中的作用:一项多变量随访研究。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):839-849. doi: 10.31557/APJCP.2022.23.3.839.
2
Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.上皮-间质转化与肝细胞癌患者较短的无病生存期相关。
Ann Surg Oncol. 2014 Nov;21(12):3882-90. doi: 10.1245/s10434-014-3779-2. Epub 2014 May 15.
3
Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.卷曲蛋白2(Frizzled 2)表达在肝细胞癌中的临床意义及其与上皮-间质转化的关系
Int J Oncol. 2017 May;50(5):1647-1654. doi: 10.3892/ijo.2017.3937. Epub 2017 Mar 27.
4
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.FoxM1过表达促进肝细胞癌的上皮-间质转化和转移。
World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.
5
MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.微小RNA-122通过靶向Snail1和Snail2并抑制WNT/β-连环蛋白信号通路来抑制肝细胞癌中的上皮-间质转化。
Exp Cell Res. 2017 Nov 15;360(2):210-217. doi: 10.1016/j.yexcr.2017.09.010. Epub 2017 Sep 8.
6
Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.CD13及上皮-间质转化(EMT)标志物在肝细胞癌中的临床意义
Jpn J Clin Oncol. 2018 Jan 1;48(1):52-60. doi: 10.1093/jjco/hyx157.
7
Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.Runt 相关转录因子 3 逆转肝癌中的上皮-间充质转化。
Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24.
8
Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.在不同疾病阶段的肝癌患者的循环肿瘤细胞中表达的上皮-间充质转化标志物。
Cell Death Dis. 2013 Oct 3;4(10):e831. doi: 10.1038/cddis.2013.347.
9
Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.UBAP2L的下调通过调控SNAIL1抑制肝癌细胞的上皮-间质转化
Cell Physiol Biochem. 2017;41(4):1584-1595. doi: 10.1159/000470824. Epub 2017 Mar 27.
10
Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.长链非编码RNA HOST2通过激活JAK2-STAT3信号通路促进肝癌细胞的上皮-间质转化、增殖、侵袭和迁移。
Cell Physiol Biochem. 2018;51(1):301-314. doi: 10.1159/000495231. Epub 2018 Nov 19.

引用本文的文献

1
Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid Differentiation.一例伴有肉瘤样分化的肝细胞癌患者的自发性肿瘤溶解综合征
Indian J Surg Oncol. 2024 Jun;15(2):370-374. doi: 10.1007/s13193-024-01895-0. Epub 2024 Feb 13.
2
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma.系统整合分子和临床方法在 HCV 诱导的肝细胞癌中的应用。
J Transl Med. 2024 Mar 12;22(1):268. doi: 10.1186/s12967-024-04925-1.
3
Polyhydroxylated Fullerene C(OH) Nanofilms Promote the Mesenchymal-Epithelial Transition of Human Liver Cancer Cells via the TGF-β1/Smad Pathway.

本文引用的文献

1
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma.靶向肝细胞癌中的上皮-间质转化途径。
Clin Mol Hepatol. 2020 Oct;26(4):484-486. doi: 10.3350/cmh.2020.0220. Epub 2020 Oct 1.
2
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance.直接抗病毒药物治疗后肝细胞癌的发生:评估治疗后风险和监测的分子工具
Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010.
3
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
多羟基化富勒烯C(OH)纳米膜通过TGF-β1/Smad信号通路促进人肝癌细胞的间充质-上皮转化
J Inflamm Res. 2023 Aug 29;16:3739-3761. doi: 10.2147/JIR.S415378. eCollection 2023.
4
Circular SERPINA3 and its target microRNA-944 as potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma in Egyptian population.环状丝氨酸蛋白酶抑制剂3及其靶标微小RNA-944作为埃及人群丙型肝炎病毒诱导的肝细胞癌的潜在生物标志物。
Noncoding RNA Res. 2023 May 23;8(3):401-412. doi: 10.1016/j.ncrna.2023.05.005. eCollection 2023 Sep.
5
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma.肝细胞癌术后复发转移的分子机制的最新进展。
World J Gastroenterol. 2022 Dec 14;28(46):6433-6477. doi: 10.3748/wjg.v28.i46.6433.
肝细胞癌的生物标志物:诊断、预后和治疗反应评估。
Cells. 2020 Jun 1;9(6):1370. doi: 10.3390/cells9061370.
4
Intratumoral heterogeneity and clonal evolution in liver cancer.肝癌中的肿瘤内异质性和克隆进化。
Nat Commun. 2020 Jan 15;11(1):291. doi: 10.1038/s41467-019-14050-z.
5
TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin.TXNDC12 通过激活 β-catenin 促进肝癌细胞的 EMT 和转移。
Cell Death Differ. 2020 Apr;27(4):1355-1368. doi: 10.1038/s41418-019-0421-7. Epub 2019 Sep 30.
6
Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis.上皮-间质转化诱导转录因子的过表达作为亚洲人群肝细胞癌潜在的不良预后因素:一项荟萃分析。
Oncotarget. 2017 Jun 2;8(35):59500-59508. doi: 10.18632/oncotarget.18352. eCollection 2017 Aug 29.
7
LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition.LGR5通过诱导上皮-间质转化促进肝细胞癌转移。
Oncotarget. 2017 Feb 7;8(31):50896-50903. doi: 10.18632/oncotarget.15143. eCollection 2017 Aug 1.
8
MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.MYC相关锌指蛋白通过诱导上皮-间质转化促进肝细胞癌的侵袭和转移。
Oncotarget. 2016 Dec 27;7(52):86420-86432. doi: 10.18632/oncotarget.13416.
9
Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma.紧密连接蛋白ZO-1和TWIST表达对肝细胞癌患者术后生存的影响
Dig Dis. 2016;34(6):702-707. doi: 10.1159/000448860. Epub 2016 Oct 17.
10
Role of EMT in Metastasis and Therapy Resistance.上皮-间质转化在转移和治疗抗性中的作用。
J Clin Med. 2016 Jan 27;5(2):17. doi: 10.3390/jcm5020017.